Dr. Burkhard Lohr, CFO

Similar documents
Dr. Burkhard Lohr, CFO

Q1/16 Conference Call May 10th, 2016

Q Conference Call May 14th, 2018

FY/Q Conference Call March 15th, 2018

FY/Q Conference Call March 16th, 2017

K+S confirms significant increase in operating earnings for 2015

Q Conference Call May 9th, 2017

From CapEx to Cash Capital Markets Day Merkers - November 12th, 2015

Q Conference Call August 14th, 2018

Q Financial Summary for Investors and Analysts

K+S Confirms Significant Increase in Operating Earnings

Revenues and earnings down on previous year s level

K+S Group achieves lower revenues and earnings

Successful Start to the Year by the K+S Group

Kepler Cheuvreux GCC 2019

K+S Group expects slight increase in revenues and earnings in the current year

Commerzbank Sector Conference 2017

Merck FY/Q Financial Summary for Investors and Analysts

K+S Group increases revenues in the first half of 2013

Roadshow Hamburg 8 June 2016

Q1/18 Quarterly Report K+S GROUP

Merck FY/Q Financial Summary for Investors and Analysts

PRESENTATION OF ANNUAL FINANCIAL STATEMENTS Norbert Steiner, CEO. 12 March 2009, Frankfurt am Main. Experience growth.

Merck FY/Q Financial Summary for Investors and Analysts

IFX Day Campeon June 24, 2010 Dr. Marco Schröter Member of the Management Board Chief Financial Officer, Labor Director

Scotiabank Fertilizer & Chemicals Conference Toronto 20 September 2016

Q Financial Summary for Investors and Analysts

HALF-YEARLY FINANCIAL REPORT OF THE K+S GROUP JANUARY TO JUNE

K+S Group confirms outlook for 2012

Goldman Sachs Seventh Annual European Chemicals Conference

QUARTERLY FINANCIAL REPORT OF THE K+S GROUP JULY TO SEPTEMBER

Q Conference Call Presentation. Dr. Christoph von Plotho, CEO Rainer Irle, CFO July 31, 2015

Quarterly Report Q1/07 January March

HALF-YEARLY FINANCIAL REPORT OF THE K+S GROUP JANUARY TO JUNE. + K+S rejects takeover proposal from PotashCorp

Half-yearly Financial Report H1/07 Quarterly Report Q2/07

Workshop II Shaping 2030 from a Financial Perspective

Roadshow Amsterdam 8 December 2016

Q Conference Call Presentation. Dr. Christoph von Plotho, CEO Rainer Irle, CFO October 29, 2015

H1/17 Half-Yearly Financial Report K+S GROUP

BEFESA BEFESA. Second Quarter 2016 Earnings Presentation

H1/16 Half-Yearly Financial Report K+S GROUP

TI Fluid Systems plc Results Presentation for TI Fluid Systems plc 20 March 2018

Conference Call Q Results. Analysts Conference Call 30 April 2015

+ Good sales volumes of Potash and Magnesium Products continue + Salt business still significantly above last year + Revenues of the first half year

Q Results. Strong start in May 3, 2016

Philips Lighting reports 0.5% full year comparable sales growth, 10% operational profitability and EUR 403 million free cash flow

Investor Conference Call

Fredrik Nilsson Chief Financial Officer and acting Chief Executive Officer. CFO update. The Co-Development Company

Interim Report Q4 FY 17

Analyst & Investor Fact Sheet Q3 2017

BEFESA BEFESA. Fiscal Year 2015 Earnings Presentation

Conference Call FY 2016/17 Preliminary results for the Financial Year 2016/17

Linde Group. First Nine Months 2004 Conference Call. November 11, Dr. Peter Diesch, CFO

1 ST QUARTER 2013 CALL NOTE

Merck FY/Q Financial Summary for Investors and Analysts

Q1-Q results 8 November 2016 Dr Helmut Leube, CEO Dr Margarete Haase, CFO

Q Earnings Presentation. Rainer Beaujean, Speaker of the Management Board and CFO April 12, 2018

IFX Day Campeon 07 June Dominik Asam Member of the Management Board Chief Financial Officer

Full Year Results 2014

July 26, 2017 LafargeHolcim Ltd 2015

Lehman Brothers High Yield Bond & Syndicated Loan Conference. March 16, 2005

Interim Results 6-month figures FY 11

Kuehne + Nagel International AG Analyst Conference Full-year 2016 results. March 1, 2017 (CET 14.00) Zurich, Switzerland

We prioritize sustainable, profitable growth

Interim Results 9-month figures FY 14

Interim report July - September 2016

2017 Full Year Results. Tuesday 21 November 2017

Shaping 2030 Conference Call October 9 th, 2017

The Quarter in brief Q4/2010

KION UPDATE CALL Q Gordon Riske, CEO Thomas Toepfer, CFO Wiesbaden, 7 May 2015

Q results. 2 May 2018 Dr Frank Hiller, CEO Dr Andreas Strecker, CFO

Analyst & Investor Fact Sheet Q1 2018

HELLA Investor Update FY 2016/17

Interim Results 9-month figures FY 11

Joe Kaeser, President and CEO Ralf P. Thomas, CFO. Q1 Overall performance as expected Q1 FY 2015, Analyst Call Munich, January 27, 2015

3M 2017 Results VTG AG On the track for the future

H FINANCIAL RESULTS. August 30,

TI Fluid Systems plc Half Year Results Presentation for TI Fluid Systems plc. 8 August 2018

Investor Conference Call

At 1.56 billion, half year revenues rise 5% Operating earnings increase by 6% to million

Prosegur 1H 2014 Results

Strong orders continue into the new fiscal year

FY 2017 FINANCIAL RESULTS. Milan February 27 th, 2018

HELLA Investor Update Q1 2015/16

Crane Co. Financial Overview. Richard Maue, Chief Financial Officer

Siemens Gamesa Renewable Energy Q3 18 Results

At million, first quarter revenues rise by 8% Adjusted earnings per share reach 1.73/share (+21%)

Interim Report Q1 FY 18

HUGO BOSS First Nine Months Results 2011

TELENOR GROUP THIRD QUARTER Sigve Brekke, CEO

Thai Union Group Public Company Limited

Telenor Group. Jon Fredrik Baksaas, CEO DNB Nordic TMT Conference

Investor Conference Call

January March Conference Call. Georg Denoke Member of the Executive Board and CFO 04 May 2012

January March 2010 Conference Call. Georg Denoke Member of the Executive Board & CFO 4 May 2010

9M 2016 Financial Results

Quarterly Report 01/04

Q FINANCIAL RESULTS. Milan May 10 th, 2018

Analyst and Investor Conference Call Q2 2018

Analyst & Investor Fact Sheet Q3 2018

Transcription:

Experience growth. K+S Group Q3/15 Results 11 November 2015 Dr. Burkhard Lohr, CFO

Highlights Q3/15 results EBIT I of 132 million on last year s level - EBITDA up 7% to 199 million Impressive performance of Salt continues Robust performance of Potash and Magnesium Products despite tough market environment Fit for the Future delivers expected results Legacy Project On track on time on budget Guidance FY 2015: Significant increase confirmed EBIT I expected between 780-830m Attractive mid-term perspective as independent company 2020 EBITDA goal of ~ 1.6bn reaffirmed K+S Group 2

P&L Q3/15 EBIT I significantly improved million Q3/14 Q3/15 YoY Revenues 827 891 +8% EBITDA 187 199 +7% D&A -53-67 EBIT I 134 132-1% t/o insurance payment 6 - EBIT I w/o insurance payment 128 132 +3% Margin 16% 15% Financial result -24-7 EBT, adjusted 110 125 +14% Tax rate, adjusted 31% 29% Net income, adjusted 76 89 +17% EPS, adjusted 0.40 0.46 Improved pricing in Salt and positive Fxeffects offset lower sales volumes in potash Bond repayment in September 2014 and capitalization of interest costs for Legacy The adjusted key figures only include operating forecast hedges of the respective reporting period in EBIT I. In addition, related effects on deferred and cash taxes are also excluded. K+S Group 3

Salt pricing and Fx balancing potash volumes EBIT I million 6 Main effects - Insurance payment Q3/14 5 Main effects - Incremental OpEx Legacy 20 29 Main effects + Higher average selling price in salt - Lower volumes in potash Main effects - Mainly potash USD 134 132 Q3/14 Insurance payment 2014 Incremental Legacy OpEx Price/ Volume Fx/ Other Q3/15 K+S Group 4

Cash flow and net debt CapEx increased as planned million 9M/14 9M/15 YoY Operating cash flow 624 630 +1% - Investing cash flow (pre sale/ purchase of securities) -646-894 Adjusted free cash flow -22-264 CapEx 731 905 +24% Mainly investments Legacy 30/09/14 31/12/14 30/09/15 Net debt -1,305-1,676-2,224 t/o Net financial debt (-) -275-588 -1,005 Planned CapEx for the Legacy Project and adjustment of interest rates on provisions ( -115 million) in Q1/15 K+S Group 5

Potash and Magnesium Products Average selling price up YoY stable QoQ in /t 400 350 300 250 200 2011 K+S average portfolio prices 2012 2013 2014 Total Europe Overseas Prices in USD converted into Euro with quarterly average fx-rates. Q3/14: 279 Q2/15: 310 Q3/15: 310 2015 Market Low soft commodity prices and liquidity issues for farmers in Brazil limiting fertilizer offtakes South East Asia seasonally quiet Europe with solid pricing but sluggish demand K+S product portfolio Overall average selling price still at high level Europe driven by Q3 production constraints and reluctance of markets Overseas emerging demand pressure mainly in MOP SOP pricing and demand resistant K+S Group 6

Potash and Magnesium Products Business unit performance Underlying result robust million Q3/14 Q3/15 YoY Revenues 451 471 +4% EBITDA 134 127-5% EBIT I 111 93-16% t/o insurance payment 4 - EBIT I w/o insurance payment 107 93-13% Margin 22% 20% t/o Legacy OpEx -10-15 Average selling price ( /ton) 279 310 +11% Sales volumes (million tons) 1.62 1.52. Higher depreciation, increase in Legacy costs, missing insurance payment and lower sales volumes due to production constraints Costs/ton (1,2) FY/13 FY/14 Q1/15 Q2/15 Q3/15 LTM Excl. Legacy 211 203 212 209 239 223 Incl. Legacy 214 208 219 221 249 232 (1) (Revenues EBIT)/ Sales volumes (2) Excl. insurance payment Costs per ton mainly affected by lower volumes, higher depreciation and maintenance K+S Group 7

Potash and Magnesium Products Legacy Project status: On time and budget ~70% of CapEx spent 2014 and 2015 years of main construction and CapEx Main parts awarded to suppliers 100% 100% 50% Sustaining CapEx going forward 50% 0% 2013 2014 2015 2016 2017 0% August 2015 September 2015 October 2015 K+S Group 8

Salt Business unit performance EBIT I driven by improved pricing million Q3/14 Q3/15 YoY Revenues 335 382 +14% EBITDA 50 71 +40% EBIT I 25 43 +72% Margin 7% 11% Better pricing Sales volumes (million tons) 3.9 3.8 De-icing 1.6 1.5 Non de-icing 2.3 2.3 Base effect after record Q3/14 Average selling prices ( ) De-icing 51.8 61.8 +19% Non de-icing 104.1 124.0 +19% Higher average selling prices in North America and Europe Non de-icing improved pricing structure and positive fx-effects K+S Group 9

Guidance FY 2015: Underlying assumptions FY 2015e YoY Prev. guidance FY 2014 Potash and Magnesium Products Global sales volumes (1) Moderate decline Moderate decline ~ 68m tons K+S sales volumes Slight decline ~ 7m tons 6.9m tons Average selling price Tangible increase Tangible increase 274 Salt K+S sales volumes On last year s level On last year s level 24m tons t/o de-icing ~ 14m tons ~ 14m tons 14m tons Group Revenues 4.3 bn - 4.5 bn 4.35 bn - 4.55 bn 3.8bn EBITDA 1.06bn-1.11 bn 1.06 bn - 1.14 bn 896m (2) EBIT I 780m 830m 780m 860m 641m (2) Financial result Significant improvement Significant improvement -126m Capex ~ 1.3bn ~ 1.3bn 1.2bn Average fx-rate (EUR/USD) 1.11 1.11 1.33 Dividend policy 40-50% payout ratio (1) Incl. 4mt of potassium sulphate and potash grades with lower mineral content (2) Incl. insurance gain of 36 m K+S Group 10

Guidance FY 2015: Significant increase confirmed million 780-830 641-36m Main effects: - Incremental OpEx Legacy - Higher D&A - Costs related to unsolicited takeover proposal by PotashCorp Main effects: + Positive impact Salt pricing + Base effect average selling price in Potash - Lower sales volumes Potash + Incremental savings + 10 cent higher Dollar equals ~ 50m benefit in EBIT I (1) + Planning assumption EUR/USD 1.11 versus average of EUR/ USD 1.33 in 2014 Actual 2014 Insurance payment Other effects Volume-/ price Fit for the Future FX 2015e (1) Valid for 2015; no linear development in both ways, after hedging K+S Group 11

Forward-looking statements This presentation contains facts and forecasts that relate to the future development of the K+S Group and its companies. The forecasts are estimates made on the basis of all the information available to us at this point. Should the assumptions underlying these forecasts prove not to be correct or should certain risks materialise, such as those referred to in the Risk Report, actual developments and events may deviate from current expectations. The Company assumes no obligation to update the statements, with the exception of disclosures required by the provisions of statute. K+S Group 12

Experience growth. K+S Group Q3/15 Results 11 November 2015 Dr. Burkhard Lohr, CFO